Roche launches mySugr Pump Control within the mySugr app to simplify insulin pump therapy via smartphone
mehr
Storys zum Thema Medikament
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
Semaglutide in people with obesity: boosts wellbeing and ability to perform daily physical activities
Bagsværd, Denmark (ots/PRNewswire) - Novo Nordisk today announced new results from the STEP phase 3a clinical trial programme, demonstrating potential benefits beyond weight loss for people with obesity being treated with semaglutide 2.4 mg. The trial showed that treatment with once-weekly semaglutide 2.4 mg led to ...
mehrRoche collaborates with Lilly to support people with diabetes on insulin pen therapy
Basel, Switzerland (ots/PRNewswire) - - Roche and Lilly will integrate data from Lilly's connected insulin pen solution into the mySugr app in several countries. - Both companies are dedicated to driving new possibilities to ease the complexity of daily decision making for people with diabetes on insulin pen therapy and their healthcare professionals. - By ...
mehrRoche collaborates with Lilly to support people with diabetes on insulin pen therapy
Basel (ots) - ● Roche and Lilly will integrate data from Lilly’s connected insulin pen solution into the mySugr app in several countries. ● Both companies are dedicated to driving new possibilities to ease the complexity of daily decision making for people with diabetes on insulin pen therapy and their healthcare professionals. ● By collaborating with Lilly, ...
mehrPain Monitoring Technology (NOL) is Shown to Reduce Postoperative Pain and Health Costs
Ramat Gan, Israel (ots/PRNewswire) - A new study from Leiden University in the Netherlands has found that monitoring pain response levels during surgery with NOL® technology (Medasense, Ramat Gan, Israel) can help reduce postoperative pain. Extrapolating the results of this study, an economic analysis has shown that by facilitating reduced postoperative pain, using ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
937 million Swiss francs for 3300 new research projects
Bern (ots) - In 2020, researchers submitted 8200 grant applications to the SNSF. 3300 of them were selected for funding in a competitive process. At short notice, the SNSF funded 73 projects on COVID-19. Thousands of SNSF-funded teams explore nature, technology and society. This generates knowledge that is a key driver of progress. In 2020, the SNSF invested 937 million francs in 3300 new projects, selected from 8200 ...
mehr
#RosaceaUnmasked by Galderma unites the rosacea community to shine light on the impact of essential COVID-19 mask-wearing this Rosacea Awareness Month
Lausanne, Switzerland (ots/PRNewswire) - - Rosacea sufferers join forces this Rosacea Awareness Month to bravely share the personal impact essential COVID-19 mask-wearing has on their skin condition - #RosaceaUnmasked encourages rosacea sufferers to speak with a doctor or dermatologist about the burden of regular ...
mehrZentiva Continues Its Expansion In Oncology With The Launch Of ALYMSYS® (bevacizumab) In 21 Countries Across Europe
Prague (ots/PRNewswire) - Zentiva and mAbxience announce their collaboration for the launch of the ALYMSYS® (bevacizumab) following its European Marketing Authorisation on March 26th. The EC approval is based on a comprehensive clinical and scientific package which demonstrated biosimilarity of ALYMSYS® to the ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
Veal calf fattening: it can work with less antibiotics
Bern (ots) - By adopting a few simple measures, farmers can drastically reduce the use of antibiotics and improve the well-being of their animals without economic disadvantages. This was confirmed in a field trial- the first of its kind in Switzerland - carried out by researchers of the University of Bern based on the specially developed "outdoor veal calf" method. Large amounts of antibiotics are used in the veal ...
mehrGrünenthal is Recognized for its Strong Management of Environmental, Social and Governance (ESG) Risks
Aachen, Germany (ots) - - Leading global ESG ratings agency Sustainalytics notes Grünenthal is in the top five percent among its peers in the pharmaceutical subindustry - Grünenthal is categorized as “medium risk”, placing it ahead of its key subindustry peers and in the same league as multinational companies ...
mehrSaxenda® recommended for approval by European Medicines Agency committee for the treatment of obesity in adolescents aged 12-17 years
Bagsværd, Denmark (ots/PRNewswire) - Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has recommended that the use of Saxenda® is expanded for the treatment of obesity in adolescents aged 12-17 years.1 Over the last 20 years, the ...
mehrPromising results from Liechtenstein study on early detection of Covid-19 / Sensory bracelet indicates infection two days before appearance of first symptoms
Vaduz (ots) - A scientific consortium led by Liechtenstein scientists and entrepreneurs Lorenz Risch and Martin Risch launched the prospective "COVI-GAPP study", involving more than 1100 subjects from the Principality of Liechtenstein, in April 2020. The aim was to show whether a sensory bracelet, already used ...
mehr
Dental disaster: One year after first lockdowns dentists around the world confront the consequences of the COVID-19 pandemic on people’s oral health: higher incidence of tooth decay and more advanced gum disease
mehrPrecision Toxicology consortium aims to protect human health from effects of harmful chemicals
Brussels (ots/PRNewswire) - A major research project to shape regulation and policy on chemical safety without the use of animal testing has been launched with the aid of EUR19.3M funding from the European Commission under H2020 program. Led by the University of Birmingham and involving 15 European and US organisations, PrecisionTox aims to protect human health from ...
mehrA Genetic Method to Predict the Effects of Personalized Treatments for Sexual Dysfunction in Women
Almere, Netherlands (ots/PRNewswire) - There is a strict embargo on this press release and article until the time of its scheduled publication (March 5th, 2021 at 2pm ET). The link to the article, which will go live upon publication: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0246828 The influential open access journal PLOS ONE published an ...
mehrPhilips and Disney join forces to improve the healthcare experience of children
Amsterdam (ots/PRNewswire) - · Philips partners with European Hospitals to conduct first of its kind clinical research pilot program that aims to help reduce fear and anxiety to improve children's patient experience during MRI exams · Study will explore the effects and use of animated stories and characters, including Disney favorites, as part of Philips Ambient ...
mehr- 2
B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®
mehr New FDI World Dental Federation global survey reveals that two-thirds of countries are not allowing dentists to administer COVID-19 vaccines
Geneva, Switzerland (ots) - Survey also shows that half of the responding countries have agreed to include dentists in their priority vaccination groups FDI World Dental Federation today called for more countries to enable dentists to administer COVID-19 vaccines after a survey of its members revealed the small ...
mehr
Galderma online survey reveals essential COVID-19 mask wearing can be worsening rosacea skin disease
Lausanne, Switzerland (ots/PRNewswire) - - Although essential for public health, new online survey findings show that people with self-reported rosacea* may be experiencing worsening of symptoms due to mask wearing, further increasing the daily burden for people living with this chronic skin disease - Despite ...
mehrSMART Medical Systems receives Additional FDA Clearance for its G-EYE® Colonoscope, and Commences Clinical Work in the USA
Ra'anana, Israel (ots/PRNewswire) - SMART Medical has now commenced clinical collaboration with NYU Langone Health introducing its newly FDA-cleared G-EYE® 760 Colonoscope series, based on FUJIFILM Corporation's 510(k) cleared 760 colonoscopes and operating with Fujifilm's state-of-the-art ELUXEO imaging system ...
mehrSOPHiA GENETICS and the Spanish Lung Cancer Group Team Up to Explore the Predictive Potential of Multimodal Health Data in Resectable Stage IIIA Non-Small Cell Lung Cancer
Lausanne, Switzerland and Boston (ots/PRNewswire) - SOPHiA GENETICS, a global leader in Data-Driven Medicine, announced today a clinical research partnership initiative with the Spanish Lung Cancer Group to apply its radiomics and multimodal analysis capabilities to predict response to neoadjuvant chemoimmunotherapy ...
mehrSOPHiA GENETICS Appoints Influential Regulatory Figure Kathy L. Hibbs to Board of Directors
Boston and Lausanne, Switzerland (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Kathy L. Hibbs was nominated to the company's Board of Directors and its Audit Committee. Hibbs is an accomplished healthcare technology executive, currently holding the position of Chief Legal ...
mehrNUCLEAI AND DEBIOPHARM LAUNCH RESEARCH COLLABORATION UTILIZING NUCLEAI’S AI-POWERED BIOMARKER PLATFORM
Tel Aviv, Israel / Lausanne, Switzerland (ots) - Nucleai (www.Nucleaimd.com), a global provider in pathology-based biomarker discovery, and Debiopharm (www.debiopharm.com), a Swiss-based biopharmaceutical company specializing in drug development, announced that they have entered into a long-term collaboration to ...
mehrServier to Acquire Agios Pharmaceuticals' Oncology Business
Paris and Boston (ots/PRNewswire) - - Transaction includes commercial, clinical and research-stage oncology portfolio and employees for up to $2 billion plus royalties - Includes Agios' marketed medicine TIBSOVO® and a strong oncology pipeline of Phase 3 and early-stage assets - Acquisition in-line with Servier's strategic ambition to become a recognized and innovative player in oncology, supported by unique drug ...
mehr
Tianjin Jinyun New Media Group
Tianjin Jinyun New Media Group presents a video on Scientific Traditional Chinese Medicine
Tianjin, China (ots/PRNewswire) - Traditional Chinese Medicine has played an important role in the worldwide fight against COVID-19. This short video introduces TCM's cultural inheritance, anti-epidemic achievements, its scientific and technological innovation and its efforts to safeguard human health and protect people's lives. Contact: Yan Zheng Tel: 0086-18622969907 ...
mehrEANS-News: AGRANA: Weekly rapid coronavirus tests for employees prove their worth
issuer: AGRANA Beteiligungs-AG F.-W.-Raiffeisen-Platz 1 A-1020 Wien phone: +43-1-21137-0 FAX: +43-1-21137-12926 mail: info.ab@agrana.com WWW: www.agrana.com ISIN: AT000AGRANA3 indexes: WBI stockmarkets: Frankfurt, Berlin, Stuttgart, Wien language: ...
mehrNovaliq Announces First Patient Randomized in the Phase 3 trial ESSENCE-2 of CyclASol® Topical Ophthalmic Solution for the Treatment of Dry Eye Disease
Heidelberg, Germany (ots/PRNewswire) - - ESSENCE-2 is the second registration trial to complete the clinical development of CyclASol® as agreed with U.S. Food and Drug Administration (FDA) - Designed to replicate efficacy demonstrated in previous phase 2/3 ESSENCE-1 trial - Topline data expected in 2nd half 2021 ...
mehrFresenius Kabi Deutschland GmbH
Fresenius Kabi and ASPEN partner for an expert interview series on omega-3 fatty acid containing parenteral nutrition
BAD HOMBURG (ots) - Evidence indicates that omega-3 (?-3) fatty acid containing parenteral nutrition (PN) improves clinical outcomes compared with standard PN in adult patients,1 underlining its role in today's hospitals and clinics. To support continuous health care professional (HCP) education on omega-3 fatty ...
mehrGH Research Ltd. Announces Completion of Phase 1 Clinical Study with GH001 (5-Methoxy-N,N-Dimethyltryptamine) in Healthy Volunteers and Updates on Further Progress
Dublin (ots/PRNewswire) - GH Research Limited ("GH Research" or "the Company") today announced the successful completion of a Phase 1 clinical study with GH001 in healthy volunteers. The Company is currently recruiting for a Phase 1/2 clinical study with GH001 in patients with Treatment-Resistant Depression. GH ...
mehrBram Goorden joins SOPHiA GENETICS as Chief Commercial Officer and Head of North America
Boston and Lausanne, Switzerland (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Bram Goorden joined its Executive team, holding the dual role of Chief Commercial Officer and Head of North America. Goorden comes to SOPHiA from Foundation Medicine Inc. (Cambridge, MA) where he held the role of VP of International Business and ...
mehr
Vorherige567891011121314Nächste